Martingale Asset Management trimmed its stake in Regeneron Pharmaceuticals by 6.9% last quarter, selling off 1,503 shares.

A federal judge tossed a lawsuit accusing Bristol Myers of monopolizing the blood cancer drug Pomalyst using shady patent ...

NPPA revises ceiling price of diagnostic agent following DoP's review order: Gireesh Babu, New Delhi Monday, April 14, 2025, 08:00 Hrs [IST] The National Pharmaceutical Pricing Au ...

A group of lawmakers have come together to flip the board on an economy they say is controlled by monopolies, where a few ...

Last November’s election ushered in a new administration, a new Congress, and a new political agenda. One of the Trump ...

Pharma giant dodges threat as US judge dismisses monopoly claims over its blockbuster cancer drug | FDA approves new ...

China - Interpretation Of The Anti-Monopoly Guidelines For Pharmaceutical Sector: Key Risk Considerations. Legal News and ...

The FDA approved the use of Opdivo with Yervoy in front-line colorectal cancer, while a Manhattan court junked a class action ...

The Hatch Waxman Act and the Biological Price Competition and Innovation Act have incentivized efforts to improperly prolong the monopolies on existing drugs. It’s time for reform.

Kunal Kamra calls out T-Series for issuing copyright strike against his video, stating it adheres to fair use. He emphasizes the potential threat to creators if such actions continue and ...